Literature DB >> 21052815

Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan.

Che-Chun Su1, Jia-Ling Lu, Kuo-Yang Tsai, Ie-Bin Lian.   

Abstract

BACKGROUND: Excessive arsenic intake has a detrimental effect on human health, as reflected in an increase in cancer incidence. In an area on the southwest coast of Taiwan, arsenic intake from well water since the 1920s had caused an exceptionally high mortality from cancer. Municipal water has become available to people living in the arseniasis endemic area since the early 1970s. This study explored the impacts of reduction in arsenic intake from water on lung cancer and bladder cancer in the arseniasis endemic area in Taiwan.
METHODS: Chart records of 23,013 patients diagnosed with bladder cancer and 93,633 patients with lung cancer from 1979 to 2003 were retrieved from the Taiwan Cancer Registry Center. We used the age-period-cohort model to study the changes in the incidence of lung cancer and bladder cancer in the arseniasis endemic area and the rest of Taiwan.
RESULTS: Three decades after municipal water supply to the arseniasis and black foot disease endemic area (BFDEA), we saw a marked decrease in the incidence of both bladder cancer and lung cancer in the area, especially for those in the later cohorts. The relative risk (RR) of getting a bladder cancer for people living in BFDEA when compared with those in the rest of Taiwan has dropped from 20 for the early cohorts to 5 for the late cohorts. As to lung cancer, the RR has decreased from 8 to between 1.5 and 2.
CONCLUSION: Reduction in arsenic intake from water has a positive impact on the incidence of both lung and bladder cancer; however, while RR for lung cancer has dropped to below 2, RR for bladder cancer remained at around 5. The difference may be because (1) there are other risk factors beside the well-water intake or (2) bladder cancer may have longer latency period for excessive arsenic exposure than lung cancer. More studies are required to understand the causes behind the difference in RR for these two types of cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052815     DOI: 10.1007/s10552-010-9679-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  6 in total

1.  Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.

Authors:  C Escudero-Lourdes; T Wu; J M Camarillo; A J Gandolfi
Journal:  Toxicol Appl Pharmacol       Date:  2011-10-10       Impact factor: 4.219

2.  Long-term treatment with arsenite activates HER1 and HER2 through upregulating EGF, TGFα, and HSP90 in a human uroepithelial cell line.

Authors:  Peiyu Jin; Jieyu Liu; Qing Zhou; Sihao Li; Weijue Liu; Shuhua Xi
Journal:  Cell Biol Toxicol       Date:  2019-11-26       Impact factor: 6.691

3.  Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide.

Authors:  Freddie Bray; Ahmedin Jemal; Lindsey A Torre; David Forman; Paolo Vineis
Journal:  J Natl Cancer Inst       Date:  2015-09-30       Impact factor: 13.506

4.  The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem.

Authors:  Marisa F Naujokas; Beth Anderson; Habibul Ahsan; H Vasken Aposhian; Joseph H Graziano; Claudia Thompson; William A Suk
Journal:  Environ Health Perspect       Date:  2013-01-03       Impact factor: 9.031

5.  Case-control study of arsenic in drinking water and lung cancer in California and Nevada.

Authors:  David C Dauphiné; Allan H Smith; Yan Yuan; John R Balmes; Michael N Bates; Craig Steinmaus
Journal:  Int J Environ Res Public Health       Date:  2013-08-02       Impact factor: 3.390

Review 6.  Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.

Authors:  Nathalie Saint-Jacques; Louise Parker; Patrick Brown; Trevor Jb Dummer
Journal:  Environ Health       Date:  2014-06-02       Impact factor: 5.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.